NCT05243953View on ClinicalTrials.gov

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
Post-Traumatic Headache
Interventions
DRUG

Levcromakalim

Study participants will be allocated to receive continuous intravenous infusion of 0.05 mg/min (20 ml of 50 mg/ml) levcromakalim.

DRUG

Placebo

Study participants will be allocated to receive continuous intravenous infusion of 20 mL placebo (isotonic saline).

Trial Locations (1)

2600

Danish Headache Center, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER